These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2952155)

  • 1. Fixed drug eruption: an immunohistochemical investigation of the acute and healing phase.
    Hindsén M; Christensen OB; Gruic V; Löfberg H
    Br J Dermatol; 1987 Mar; 116(3):351-60. PubMed ID: 2952155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T lymphocytes and phenotypically abnormal epidermal dendritic cells in fixed cutaneous eruptions.
    Murphy GF; Guillén FJ; Flynn TC
    Hum Pathol; 1985 Dec; 16(12):1264-71. PubMed ID: 2415442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of graft-versus-host reaction (GVHR)-type drug eruptions.
    Osawa J; Kitamura K; Saito S; Ikezawa Z; Nakajima H
    J Dermatol; 1994 Jan; 21(1):25-30. PubMed ID: 7908910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed drug eruptions: evidence for a cytokine-mediated process.
    Smoller BR; Luster AD; Krane JF; Krueger J; Gray MH; McNutt NS; Hsu A; Gottlieb AB
    J Cutan Pathol; 1991 Feb; 18(1):13-9. PubMed ID: 1827131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocompetent cells of fixed drug eruption.
    Visa K; Käyhkö K; Stubb S; Reitamo S
    Acta Derm Venereol; 1987; 67(1):30-5. PubMed ID: 2436411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction.
    Scheynius A; Klareskog L; Forsum U
    Clin Exp Immunol; 1982 Aug; 49(2):325-30. PubMed ID: 6751638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
    Aichinger G; Fill H; Wick G
    Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Langerhans' cell distribution in drug eruption.
    Dascalu DI; Kletter Y; Baratz M; Brenner S
    Acta Derm Venereol; 1992; 72(3):175-7. PubMed ID: 1357851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eruption of lymphocyte recovery with atypical lymphocytes mimicking a primary cutaneous T-cell lymphoma: a series of 12 patients.
    Hurabielle C; Sbidian E; Beltraminelli H; Bouchindhomme B; Chassagne-Clément C; Balme B; Bossard C; Delfau-Larue MH; Wolkenstein P; Chosidow O; Cordonnier C; Toma A; Pautas C; Ortonne N
    Hum Pathol; 2018 Jan; 71():100-108. PubMed ID: 29107664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
    Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
    J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption.
    Mizukawa Y; Yamazaki Y; Shiohara T
    Br J Dermatol; 2008 Jun; 158(6):1230-8. PubMed ID: 18363767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lichen planus. Study of the T-lymphocyte population and Langerhans cells using monoclonal antibodies].
    Fernández Bussy RA; Schmitt D; Mauduit G; Gomes MA; Thivolet J
    Med Cutan Ibero Lat Am; 1983; 11(1):17-22. PubMed ID: 6224058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerhans cells and T-lymphocytes in the normal human ectocervix defined by monoclonal antibodies and electron microscopy.
    Roig de Vargas-Linares C
    Microsc Electron Biol Celular; 1989 Jun; 13(1):53-63. PubMed ID: 2636973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic pulmonary transplant rejection.
    Hasegawa S; Ockner DM; Ritter JH; Patterson GA; Trulock EP; Cooper JD; Wick MR
    Arch Pathol Lab Med; 1995 May; 119(5):432-9. PubMed ID: 7748071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical studies of Langerhans cells and keratinocytes and T cell subsets in oral lichen planus by anti-T6, anti-HLA-DR, and anti-T3, T4, T8].
    Peng CY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1994 Mar; 29(2):105-7. PubMed ID: 8001425
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
    Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
    Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is new in fixed drug eruption?
    Shiohara T
    Dermatology; 1995; 191(3):185-7. PubMed ID: 8534934
    [No Abstract]   [Full Text] [Related]  

  • 19. Histological and immunochemical studies of oral leukoplakia: phenotype and distribution of immunocompetent cells.
    Bondad-Palmario GG
    J Philipp Dent Assoc; 1995; 47(1):3-18. PubMed ID: 9227108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation.
    Schmid S; Kuechler PC; Britschgi M; Steiner UC; Yawalkar N; Limat A; Baltensperger K; Braathen L; Pichler WJ
    Am J Pathol; 2002 Dec; 161(6):2079-86. PubMed ID: 12466124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.